{"id":"W4317567968","doi":"10.1007/s40744-022-00529-7","title":"Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies","year":2023,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Chugai Pharmaceutical; Genentech; Astellas Pharma; National Institute for Health and Care Research; Biogen; Celgene; Gilead Sciences; Nordic Pharma Group; Eisai; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Rheumatoid arthritis; Medicine; Disease; Dermatology; Arthritis; Internal medicine; Physical therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004419808,0.0003040827,0.0009934555,0.000469217,0.0001396889,0.00002487689,0.00007772664,0.0001387996,0.00005393984],"category_scores_gemma":[0.0004048171,0.0002273249,0.00008801941,0.0006531317,0.0005931421,0.0001605563,0.00004463871,0.0003804635,0.0000296443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003125561,"about_ca_system_score_gemma":0.0001434646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001415674,"about_ca_topic_score_gemma":0.000309006,"domain_scores_codex":[0.9973598,0.0003966271,0.000795295,0.0005264341,0.0002938528,0.0006279569],"domain_scores_gemma":[0.9986126,0.0005904509,0.0000912669,0.0002711595,0.000139247,0.0002952746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005608397,0.0009091351,0.8832953,0.00003615874,0.0002067092,0.0006697897,0.00142097,0.000001435499,0.00001688953,0.0002995805,0.0002354771,0.1073002],"study_design_scores_gemma":[0.0464327,0.003867823,0.9418913,0.0015225,0.000002143934,0.000132654,0.0012292,0.0001675789,0.0001130549,0.001033572,0.003245422,0.0003620893],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9684716,0.02968612,0.000001847868,0.0006687941,0.0001289638,0.0008346809,0.0000315644,0.0001301373,0.00004630789],"genre_scores_gemma":[0.6233025,0.3763398,0.00001842533,0.00008705877,0.000004881708,0.0001598878,0.00005300385,0.0000246695,0.000009742257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3466537,"threshold_uncertainty_score":0.927004,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03791251253965131,"score_gpt":0.3451770614039854,"score_spread":0.3072645488643341,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}